Table 1—

Demographics and baseline characteristics of pramlintide-treated subjects

Sex (M/F)8/10
Race (caucasian/other)14/4
Age (years)44 ± 11
Weight (kg)78.0 ± 18.2
BMI (kg/m2)28.0 ± 5.0
Diabetes duration (years)25 ± 10
HbA1c (%)8.2 ± 1.3
Serum fructosamine (μmol/l)339 ± 64
Mealtime insulin bolus (units)7 ± 5
Insulin type lispro/regular16/2
Fasting plasma glucose (mg/dl)*169 ± 15
Fasting plasma glucagon (pg/ml)65 ± 5
Fasting plasma triglycerides (mg/dl)81 ± 9
  • Data are means ± SD.

  • *

    * Conversion to SI units: value × 0.055.